An increase in CD4 cytotoxic T cells was found in a mouse pancreatic cancer model after the administration of an antigen-specific dendritic cell (DC)-targeted vaccine, and this effect was enhanced when combined with anti-CTLA4 therapy (156). This evidence concerns the gene CD4 and familial pancreatic carcinoma.